Philippines Pharmaceuticals & Healthcare Q3 2018
The expansion of PhilHealth, with the aim of achieving universal coverage, will continue to be an important driver ofpharmaceuticals and healthcare market growth. While the country's disease profile will continue to evolve in line with economic anddemographic trends and will provide a number of revenue earning opportunities for pharmaceutical firms, a multitude of regulatoryissues will create challenges while policies implemented to control expenditure will become more prominent. The constraints onaffordability and the demand for low-cost pharmaceuticals will spur greater investment from drugmakers with strong generic drugportfolios.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook